A Design-Around Solution for a MMX-Based Tablet Drug Comprising Mesalazine —A Lesson from Shire Development, LLC v. Watson Pharmaceuticals, Inc.

Biotechnology Law Report, Ahead of Print.

Source: Biotechnology Law Report - January 26, 2020 Category: Medical Law Authors: Ping-Hsun Chen Source Type: research